find a clinical trial
If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at 201-518-3587, or email us.
351
Clinical Trials
Multiple Myeloma
N/A
Enrolling
nct/study# N/A / MOFFIT-CHIMERIC
Characteristics and Outcomes of Patients with Multiple Myeloma Treated with Chimeric Antigen Receptor T Cell Therapy”
Learn More
Multiple Myeloma
N/A
Enrolling
nct/study# N/A / MOLECULAR-ANALYSIS-IST
Prognostic significance of cytogenetic abnormalities and molecular classification on mortality and morbidity at Hackensack Meridian Health in patients treated for multiple myeloma
Learn More
Multiple Myeloma
N/A
Enrolling
nct/study# N/A / ONJ-MYELOMA
Comparative Analysis of Osteonecrosis of the Jaw Incidence in Multiple Myeloma Patients Treated with Denosumab vs. Bisphosphonates: A Retrospective Cohort Study
Learn More
Multiple Myeloma
N/A
Enrolling
nct/study# N/A / SIND-175709-BELANTAMAB-S-G
Single Patient Non-Emergency Use IND of Belantamab Mafodotin for Patient S-G
Learn More
Multiple Myeloma
N/A
Enrolling
nct/study# N/A / SIND-179041-BELANTAMAB-P-L
Single Patient Non-Emergency Use IND of Belantamab Mafodotin for Patient P-L
Learn More
Neuro-Oncology
Phase III
Enrolling
nct/study# NCT06556563 / EF-41-KEYNOTE-D58
Tumor Treating Fields (TTFields) with maintenance temozolomide (TMZ) and pembrolizumab versus TTFields concomitant with maintenance TMZ and placebo in participants with newly diagnosed glioblastoma. Keynote D58
Learn Morewe are here for you
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.